Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT04760483

Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA

Soractelite(Tm) Transperineal Laser Ablation for Benign Prostatic Hyperplasia With Bladder Outlet Obstruction

Sponsor: Urological Research Network, LLC

Conditions Genital Diseases, Male Male Urogenital Diseases Prostatic Disease Prostatic Hyperplasia

Interventions SoracteLite(TM) TPLA for BPH

Updated 5 times since 2021 Last updated: Jan 24, 2023 Started: Nov 20, 2020 Primary completion: Mar 19, 2022 Completion: Mar 20, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04760483, this PHASE1 trial focuses on Genital Diseases, Male and Male Urogenital Diseases and remains ongoing. Sponsored by Urological Research Network, LLC, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE1
Feb 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting · Phase: NA → PHASE1
Mar 2022 — Feb 2023 [monthly]

Recruiting NA

Phase: PHASE1 → NA
Mar 2021 — Mar 2022 [monthly]

Recruiting PHASE1

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Urological Research Network, LLC

Data source: Urological Research Network, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hialeah, United States